ReproCELL Incorporated (FRA:6RC)

Market Cap	82.88M
Revenue (ttm)	15.16M
Net Income (ttm)	-1.61M
Shares Out	n/a
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.7650
Previous Close	0.7450
Day's Range	0.7650 - 0.7650
52-Week Range	0.3660 - 1.3800
Beta	n/a
RSI	58.77
Earnings Date	Feb 6, 2026

About ReproCELL

ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, and synfire induced neurons; 3D cell culture; and labware. The company also provides research stem cell, genomics, clinica...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2003
• Employees: 99
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 6RC

Financial Performance

Financial numbers in JPY